Go to KM Summary
ID Title Last Updated Sort descending KM Node Tags
1939 Equipment Required in Different Rooms in the LPA Lab Facility 17/06/2022
1938 Electrical Supply and Back-up Power Requirements in LPA Facilities 17/06/2022
1935 Incubation of MGIT Tubes 17/06/2022
1917 Overview of the Truenat Testing Process 17/06/2022
2187 Truenat MTB and RIF Assay as a TB Diagnostic Test 17/06/2022
331 Positive and Negative predictive value for a test 17/06/2022
589 Interaction of STS with TB Patient Care Ecosystem 17/06/2022
607 Management of Adverse Drug Reactions(ADRs) of TB Treatment 17/06/2022
613 How to register on Nikshay as Treatment Supporter /Informant? 17/06/2022
692 Socio-Economic Determinants for Tuberculosis 17/06/2022
1930 Procedure for Culture Specimen Processing: Urine 17/06/2022
1931 Procedure for Culture Specimen Processing: CSF and other body fluids 17/06/2022
1932 Preparation of PANTA for MGIT TB Cultures 17/06/2022
1933 Preparation of MGIT Tubes for MGIT TB Cultures 17/06/2022
1934 Inoculation of MGIT Tubes 17/06/2022
1929 Procedure for Culture Specimen Processing: Tissue 17/06/2022
1928 Procedure for Culture Specimen Processing: Laryngeal Swab 17/06/2022
1927 Procedure for Culture Specimen Processing: Bronchial Lavage 17/06/2022
1926 Specimen Processing for TB Cultures 17/06/2022
1921 Monitoring Quality Indicators of Truenat 17/06/2022
1919 Processing of Sputum Sample before Truenat Testing 17/06/2022
1915 External Quality Assurance for CBNAAT 17/06/2022
1879 Management of DR-TB ADR: Dysglycaemia and Hyperglycemia 17/06/2022
1878 Management of DR-TB ADR: Lactic Acidosis 17/06/2022
1877 Management of DR-TB ADR: Superficial Fungal Infection and Thrush 17/06/2022
1876 Management of DR-TB ADR: Alopecia 17/06/2022
22 Mandatory Notification of TB Diagnosis 17/06/2022
1875 Management of DR-TB ADR: Electrolyte Disturbances 17/06/2022
1874 Management of DR-TB ADR: Optic Neuritis 17/06/2022
977 List of Drugs that can be Used Safely or Avoided along with Bedaquiline 17/06/2022